| WUXI BIOLOGICS UNSP.ADR/2 |
| USA |
| Gesundheit |
| US98260N1081 / A2PQ3Q |
| 1FW1 (Frankfurt) |
| FRA:1FW1, ETR:1FW1, 1FW1:GR |
| - |
| https://www.wuxibiologics.. |
|
WuXi Biologics (Cayman) Inc. American Depositary Receipt (ADR) represents shares of the China-based company WuXi Biologics, a leading global contract development and manufacturing organization (CDMO). The primary function of the ADR is to facilitate ..
>Volltext.. |
| 15937.71 Mio. EUR |
| 15089.47 Mio. EUR |
| 2627.93 Mio. EUR |
| 1012.07 Mio. EUR |
| 591.75 Mio. EUR |
| 0.29 EUR |
| 384.81 Mio. EUR |
| 1142.76 Mio. EUR |
| - |
| 1.89 |
| 16.88% |
| 46.44% |
| - |
| - |
| - |
| - |
| WUXI BIOLOGICS ADR, WUXI BIO, WUXI BIOLOGICS |
| 05.04.26 |
|